CFO of Relmada Therapeutics, Inc. (NASDAQ:RLMD), Shenouda Maged, sells 2,410 shares worth $84,825
According to Relmada Therapeutics, Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Feb 10 07:25 PM, company CFO, Shenouda Maged disclosed selling 2,410 shares at a cost of $35.20. At the time of this transaction (Feb 10), this trade was worth $84,825 in total. As of Feb 10, Shenouda Maged now owns 2,228 shares in total worth about $77,868.6.
For the last few recent trades made by Relmada Therapeutics, Inc. (NASDAQ:RLMD) CFO, Shenouda Maged, we have the following information:
- SEC Form 4 filing: Feb 08: Sold 3,603 shares at the rate of $35.04 per share. Total worth of this trade was $126,242. Total number of shares owned as of Feb 08 were 9,997
- SEC Form 4 filing: Feb 09: Sold 5,359 shares at the rate of $35.24 per share. Total worth of this trade was $188,843. Total number of shares owned as of Feb 09 were 4,638
- SEC Form 4 filing: Feb 02: Sold 3,100 shares at the rate of $35.04 per share. Total worth of this trade was $108,634. Total number of shares owned as of Feb 02 were 2,328
Posted by
George Daniels
on Wednesday February 10 2021, 10:48 PM EDT.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
